FDA to encourage new manufacturing sites with its PreCheck programme
By Dominic Tyer (European Pharmaceutical Review)
AI Act: data governance and compliance strategy implications in Pharma
By Patrice Navarro (Clifford Chance)
Biowaste innovation could advance green pharmaceutical production
By Catherine Eckford (European Pharmaceutical Review)
Sanofi accelerates towards its ‘factory of the future’ vision
By Dominic Tyer (European Pharmaceutical Review)
Amid FDA turmoil Sarepta’s gene therapy worries begin to ease
By Dominic Tyer (European Pharmaceutical Review)
Breaking down silos – how digital tools can transform pharma…
By Adam Cross (Hexagon), European Pharmaceutical Review